DePuy Synthes agrees to acquire Gemtrack technology from MinMaxMedical

DePuy Synthes announced a definitive agreement to acquire selective rights to develop, manufacture and commercialize Gemtrack miniature radiofrequency tracking technology from MinMaxMedical for use across its Joints portfolio, including shoulder, hip and knee, for navigation and robotic applications.

“DePuy Synthes today announced a definitive agreement to acquire selective rights to develop, manufacture and commercialize Gemtrack technology across its Joints portfolio”business.sherbrookerecord.com

• 1 source
• business.sherbrookerecord.comContact Us - Sherbrooke Record - DePuy Synthes Announces Agreement to Acquire Miniature Radiofrequency Tracking Technology Across its Joint Reconstruction PortfolioDePuy SynthesMay 25, 2018

Summarized from public sources; check the original articles before acting on it.